Hemophilia C overview
Hemophilia C is a rare bleeding disorder that affects the blood’s ability to clot.
Search results for:
This Thanksgiving, I am thankful for the changes in hemophilia care
Moving is challenging. Moving means packing, having to decide what to keep and what not to keep, learning a new place, having to find a new grocery store, a new hair and nail salon, a new healthcare provider. Doing all that this time offered an opportunity to remember and…
For women with hemophilia, vigilance isn’t pathology
I had previously heard about the term health anxiety obsessive-compulsive disorder (also known as hypochondriasis or illness anxiety disorder), so one day I decided to research its symptoms. Frequent visits to doctors and the emergency room, seeking reassurance that you are not ill from physicians, friends, and family, and…
November 18, 2025
by Bionews Staff
‘You have the right to dream’: Building a safe, meaningful career with hemophilia
Shellye Horowitz shares her story of working through the ups and downs of hemophilia, from carrying factor to school every day to creating safety plans and finding supportive colleagues. She reflects on dreaming big, adapting with confidence, and the belief that hemophilia doesn’t…
November 11, 2025
by Susie Strachan
Hemophilia B
Hemophilia B is a rare genetic bleeding disorder that impairs the blood’s ability to clot properly.
The importance of meeting halfway in hemophilia care
I have a friend from middle school who has a special place in my heart. We call each other “friends of a lifetime.” Years can pass without us speaking to each other, but we pick up as if no time has passed at all. I am part of her family…
Surgical planning is an absolute must when you have hemophilia
Several years ago, when I was checking some incisions about a week after I had a surgical procedure, I discovered gobs of red, gelatinous goo. No scabs had formed over the incisions like they were supposed to. I have hemophilia, so thankfully, I made it through the surgery safely,…
October 31, 2025
by Andrea Lobo, PhD
Mim8 for hemophilia
Mim8 (denecimig) is an antibody therapy being developed to prevent or reduce the frequency of bleeding episodes in people with hemophilia A, with or without neutralizing antibodies (inhibitors).